Anticoagulants Market By Administration Type ( Oral, Injectable ), By Drug Type ( Factor Xa inhibitors, DTIs, Heparin, Vitamin K Antagonists ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 168

 ERC 2574


Anticoagulants Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Anticoagulants, are the chemical substances, which are used as a blood thinner, in order to curb the occurrence or increase of unwanted blood clots. These anticoagulants restricts the secretion of Vitamin K enzymes, typically called as vitamin K epoxide reductase which causes the clotting of blood. Oral anticoagulants have emerged out to be the most adopted anticoagulants all over the globe owing to its high efficacy and being noble way of treatment without any incisions. In the current scenario, thromboembolism is spreading with a fast pace globally. Anticoagulants have emerged out to be the most efficient medication therapy for the patients suffering with venous embolism, prosthetic heart valves, atrial fibrillation, and acute myocardial infarction. A high risk of stroke among the people falling in the age group of 40-60 years is a major factor which is propelling the demand for anticoagulants globally. Moreover, a continuous hike in prevalence of atrial fibrillation, especially among geriatric population, is also fueling the market growth. A major factor which is attracting the patients towards these drugs is that they have emerged out as the best alternative to the surgical AF treatment. In addition to this, rapidly growing obesity among youth and mid-aged population is also a major cause of cardiac disorders. VTE is one of the most common vascular disorders in the United States and Europe and is associated with significant mortality. As per American Heart Association, people having obesity have 2 times higher risk of VTE as compared to the people with balanced BMI. An estimate of nearly 60,000-100,000 Americans die of cardiac disorders each year. Continuously spreading awareness regarding cardiac health and favorable government initiatives would emerge out as the future growth opportunities for the very market.

The report provides detailed qualitative and quantitative analysis of the Global Anticoagulants Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely administration type and drug type in each of the major regions.

Anticoagulants Market Player Analysis -

The report presents detailed analysis of major players operating in Global Anticoagulants Market. Few of the include Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, Sanofi, Abbott Laboratories, Astrazeneca plc., Merck & Co., Inc., Genentech Inc., GlaxoSmithKline plc., Pfizer, Inc., and Novartis AG. A detailed coverage on these market players with information on their revenue from anticoagulants business, market share, gross margin and their growth strategies have been provided in the report.

Anticoagulants Market Segmentation

Global Anticoagulants market is segmented on the basis of type, application and geography. By administration type, the market is segmented into Oral and Injectable. On the basis of drug type, the market is categorized as Factor Xa inhibitors, DTIs, Heparin and Vitamin K Antagonists. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Anticoagulants Market Segmentation

By Administration Type
   • Oral
   • Injectable

By Drug Type
   • Factor Xa inhibitors
   • DTIs
   • Heparin
   • Vitamin K Antagonists

Anticoagulants Market By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K.
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Anticoagulants Market Key Players

• Bayer HealthCare
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Daiichi Sankyo
• Johnson & Johnson
• Sanofi
• Abbott Laboratories
• Astrazeneca plc
• Merck & Co., Inc.
• Genentech Inc.
• GlaxoSmithKline plc
• Pfizer, Inc.
• Novartis AG.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Anticoagulants Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Anticoagulants Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!